PT  - JOURNAL ARTICLE
AU  - Heinrich Iber
AU  - Edward T. Morgan
TI  - Regulation of Hepatic Cytochrome P450 2C11 by Transforming Growth Factor-β, Hepatocyte Growth Factor, and Interleukin-11
DP  - 1998 Oct 01
TA  - Drug Metabolism and Disposition
PG  - 1042--1044
VI  - 26
IP  - 10
4099  - http://dmd.aspetjournals.org/content/26/10/1042.short
4100  - http://dmd.aspetjournals.org/content/26/10/1042.full
SO  - Drug Metab Dispos1998 Oct 01; 26
AB  - Injection of rats with bacterial lipopolysaccharide down-regulates P450 (P450) 2C11 (2C11) mRNA to about 20% of its control levels after only 6 hr, and this level is maintained for at least 48 hr. Although we and others have demonstrated that this effect may be at least partially mediated by the cytokines interleukin-1, interleukin-6, and tumor necrosis factor-α, as well as by glucocorticoids, the time courses and potencies of 2C11 repression by each single mediator suggested that no cytokine alone is responsible for the entire time course of 2C11 suppression during inflammation. Here, we show that transforming growth factor-β, hepatocyte growth factor, and interleukin-11 are potent inhibitors of 2C11 expression. In all three cases, 0.1 ng/ml was enough to down-regulate 2C11 mRNA levels to 50% of control. Interleukin-8, a cytokine that is secreted during the acute phase response but does not influence the liver acute phase response, did not affect 2C11 expression. The various mediators have different time courses of 2C11 down-regulation, indicating that the roles of each may be different at different phases of the response. The American Society for Pharmacology and Experimental Therapeutics